Cargando…
Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer
OBJECTIVES: To observe the risk factors affecting the occurrence of RP after gemcitabine-based induction chemotherapy. METHODS: Between January 2010 and December 2017, patients with NSCLC received gemcitabine or docetaxel chemotherapy, followed by radiotherapy at Zhejiang cancer hospital were enroll...
Autores principales: | Sheng, Liming, Cui, Xiaoying, Cheng, Lei, Chen, Ying, Du, Xianghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916068/ https://www.ncbi.nlm.nih.gov/pubmed/31842910 http://dx.doi.org/10.1186/s13014-019-1440-8 |
Ejemplares similares
-
High incidence of radiation pneumonitis in lung cancer patients with chronic silicosis treated with radiotherapy
por: Shen, Tianle, et al.
Publicado: (2019) -
Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer
por: Torresan, Sara, et al.
Publicado: (2023) -
Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
por: Ding, Xiao, et al.
Publicado: (2011) -
High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis
por: Szejniuk, Weronika Maria, et al.
Publicado: (2021) -
Grade 4 Pneumonitis in a Patient Treated with a Combination of Gemcitabine and Docetaxel for Recurrent Leiomyosarcoma of the Uterus
por: Wang, Connor, et al.
Publicado: (2020)